Alcohol overuse has a significant impact on the health and health care needs of geriatric patients. Systematic screening of all patients reduces the chance that alcohol overuse will be missed. Once identified, at-risk individuals can benefit from brief interventions in clinic or community settings.
One in six older adults self-report heavy drinking; fortunately older patients have been shown to respond well to brief alcohol use intervention protocols designed for the primary care clinic.
Findings from the Canadian Addictions Survey (2004) indicate that 16% of adults age 55 and older report heavy drinking, defined as more than 14 drinks a week for men and 9 drinks for women, and almost half of these heavy drinkers report consuming more than 5 drinks on one occasion at least once a month.
Alcohol overuse has a significant impact on the health and health care needs of these individuals. It is associated with poor mental health functioning, as well as increased risk of suicide, liver disease, cancer, and falls.[3-5] Although researchers have identified health benefits from light to moderate drinking,6 at-risk or heavy drinking is associated with increased mortality.[5,7]
At-risk drinking patterns in geriatric patients must be identified to initiate treatment of this modifiable health risk. Geriatric patients often present with multiple medical problems exacerbated by alcohol and may not fit the expected profile of a chronic drinker. It is common for patients to minimize the impact of their alcohol use, and clinicians too may gloss over alcohol use assessment in the elderly patient.
Drinking can increase in later life in response to loneliness and grief, or persist as an outlet used throughout adult life to dull emotional pain. Cognitively impaired seniors may drink more than they realize.
Impact of alcohol overuse
Alcohol overuse affects all age groups, but poses an additional risk to ill older adults in terms of adverse interactions between alcohol and both prescribed and over-the-counter medications, especially psychoactive medications such as benzodiazepines, anticonvulsants, and antidepressants. In a survey of 83321 older outpatients, 19% of those taking prescription medications known to adversely interact with alcohol reported concomitant alcohol use.
Alcohol use can adversely affect comorbid diseases common in the elderly. Relatively low consumption levels can worsen common chronic medical problems such as hypertension, coronary artery disease, and diabetes, as well as increase the difficulty of managing them.
The acute cognitive effects of alcohol use are well known, but less well studied are the long-term effects of chronic alcohol use on brain function, particularly among older individuals. Alcohol intoxication can cause cognitive effects such as disinhibition, ataxia, and short-term memory impairment.
Historically, the Wernicke-Korsakoff syndrome was considered to entirely explain the dangers of chronic alcohol use, but current data indicate that alcohol-induced dementia may also be linked to loss of white matter and neurons in the hypothalamus and cerebellum. These areas may have the potential to regrow neural networks in the absence of alcohol over an extended period.
So how much alcohol is too much? The National Institute on Alcohol Abuse and Alcoholism recommends that older men (65 years or older) consume no more than one standard drink per day with a maximum of two drinks on any one occasion, or seven drinks on average per week.
The standards for older women are stricter—less than one drink per day and a maximum of four drinks per week. Another consideration is the number of drinks consumed in a single session, with five or more drinks for men and four or more for women constituting risky drinking. Four categories of alcohol use are described in Table 1.
Many screening instruments have been developed to assess alcohol use patterns in adult patients. In a survey of 853 primary care physicians and psychiatrists, only 13% used formal alcohol screening tools routinely. The systematic screening of all patients reduces the chance that alcohol overuse will be missed.
Self-administered computer or paper-based screening questions may be answered more truthfully than questions answered in person. Patients with dementia may pose a particular challenge for self-report, and collateral history will be particularly important. The Alcohol-Related Problems Survey (ARPS) was developed specifically for geriatric populations. This survey screens for alcohol’s effects among persons with declining health and increased medication use.20 Common screening instruments are described in Table 2.[21-24]
Findings from laboratory tests can be used to corroborate verbal screening results and may also be used to motivate patients to consider treatment. However, most laboratory tests are only useful for indicating prolonged heavy drinking. The most sensitive routinely available laboratory tests for excessive alcohol intake include measurement of gamma-glutamyltransferase (GGT), mean corpuscular volume, and the ratio of aspartate aminotransferase to alanine aminotransferase (AST/ALT).
The positive predictive value for GGT is only about 25% in a population that has a 10% prevalence rate of problem drinking. Carbohydrate-deficient transferrin (CDT) is elevated in 80% of individuals who have been drinking heavily within the past week, but this test is not available in all laboratories. Blood alcohol and urine alcohol testing are only useful for detection of drinking within the previous 24 hours.
Community resources for alcohol treatment vary greatly by region. Although the senior-specific addictions treatment available in larger centres may appeal to some patients, the literature supports good outcomes for mixed-age treatment. Geriatric patients have also been shown to respond well to brief intervention protocols designed for the primary care clinic (see Figure).[26,27]
Two oral medications (naltrexone and disulfiram*) are currently approved in Canada for treating alcohol dependence in the general adult population.
Naltrexone is an opiate antagonist that targets the endogenous endorphin system, reducing both the pleasure derived from drinking and the craving to drink, while disulfiram* blocks the action of aldehyde dehydrogenase and causes the accumulation of acetaldehyde when combined with alcohol for a deterrent effect. Both agents help patients reduce drinking, avoid relapse to heavy drinking, and achieve and maintain abstinence.
In a trial involving naltrexone and supportive psychosocial therapy, Oslin and colleagues (2002) compared older adults (mean age 62.6 years) with younger adults (mean age 41.7 years) in terms of compliance and treatment efficacy. The psychosocial therapy component focused on enhancing adherence to naltrexone use and motivational techniques to change addictive behaviors.
Oslin found that the older adults did better in terms of treatment adherence and reduced relapse rates, significant findings given that adherence to naltrexone therapy can be poor because of gastrointestinal side effects. The side effects from disulfiram* use are also of concern and can lead to serious and extremely unpleasant consequences.
The accumulation of acetyldehyde is potentially dangerous in the elderly, and disulfiram* should never be given to a patient with cognitive impairment. Pharmacological treatment for comorbid anxiety and depressive disorders should be considered, but is most effective after initial alcohol reduction. Many geriatric drinkers do not benefit from additional medication, and clinicians may consider offering brief but effective behavioral support to promote recovery.[27,28]
Reduction of alcohol intake can have multiple health benefits for patients with alcohol use disorders. There is demonstrated gradual improvement of cognitive ability with increasing duration of abstinence. However, in a clinically healthy population of abstinent alcohol-dependent subjects, learning and memory deficits have been reported to persist despite prolonged periods of abstinence.
Such deficits in executive functioning, learning, and concentration may lead to poor treatment outcomes even in alcohol-dependent individuals who appear to be healthy and wish to limit their drinking. Early intervention while cognitive deficits and comorbidities may be reversible is by far the better option.
Alcohol overuse in the elderly is a common and significant problem that often goes unrecognized. Clinicians can help geriatric patients avoid serious health consequences by making thoughtful inquiries, using a screening tool, and developing an appropriate treatment strategy.
This article has been peer reviewed.
1. Adlaf EM, Begin P, Sawka E (eds). Canadian Addiction Survey (CAS). A national survey of Canadians’ use of alcohol and drugs: Prevalence of use and related harms. Detailed report. Ottawa: Canadian Centre on Substance Abuse; 2005. Accessed 21 April 2010. www.ccsa.ca/Eng/Priorities/Research/CanadianAddiction/Pages/default.aspx.
2. Blow FC, Walton MA, Barry K, et al. The relationship between alcohol problems and health functioning of older adults in primary care settings. J Am Geriatr Soc 2000;48:769-774.
3. Sorock GS, Chen LH, Gonzalgo SR, et al. Alcohol drinking history and fatal injury in older adults. Alcohol 2006;40:193-199.
4. Waern M. Alcohol dependence and misuse in elderly suicides. Alcohol Alcohol 2003;38:249-254.
5. Bagnardi V, Blangiardo M, La Vecchia C, et al. Alcohol consumption and the risk of cancer: A meta-analysis. Alcohol Res Health 2001;25:263-270.
6. Byles J, Young A, Furuya H, et al. A drink to healthy aging: The association between older women’s use of alcohol and their health-related quality of life. J Am Geriatr Soc 2006;54:1341-1347.
7. Di Castelnuovo A, Costanzo S, Bagnardi V, et al. Alcohol dosing and total mortality in men and women: An updated meta-analysis of 34 prospective studies. Arch Intern Med 2000;166:2437-2445.
8. Moore AA, Beck JC, Babor TF, et al. Beyond alcoholism: Identifying older, at-risk drinkers in primary care. J Stud Alcohol 2002;63:316-325.
9. Blazer DG, Wu LT. The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults: National Survey on Drug Use and Health. Am J Psychiatry 2009;166:1162-1169.
10. Pringle KE, Ahern FM, Heller DA, et al. Potential for alcohol and prescription drug interactions in older people. J Am Geriatr Soc 2005;53:1930-1936.
11. Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension 2001;38:1112-1117.
12. Mukamal KJ, Conigrave KM, Mittleman MA, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003;348:109-118.
13. Djousse L, Biggs ML, Mukamal KJ, et al. Alcohol consumption and type 2 diabetes among older adults: The Cardiovascular Health Study. Obesity 2007;15:1758-1765.
14. Thomas VS, Rockwood KJ. Alcohol abuse, cognitive impairment, and mortality among older people. J Am Geriatr Soc 2001;49:415-420.
15. Kamarajan C, Porjesz B, Jones K, et al. Alcoholism is a disinhibitory disorder: Neurophysiological evidence from a Go/No-Go task. Biol Psychol 2005;69:353-373.
16. Harper C. The neuropathology of alcohol-related brain damage. Alcohol Alcohol 2009;44:136-140.
17. National Institute on Alcohol Abuse and Alcoholism (NIAAA). The physicians’ guide to helping patients with alcohol problems. NIH publication No. 95-3769. Bethesda, MD: NIAAA; 1995.
18. Blow FC, Oslin DW, Barry KL. Misuse and abuse of alcohol, illicit drugs, and psychoactive medication among older people. Generations 2002; 26:50-54.
19. Friedmann PD, McCullough D, Chin MH, et al. Screening and intervention for alcohol problems. A national survey of primary care physicians and psychiatrists. J Gen Intern Med 2000;15:84-91.
20. Fink A, Tsai MC, Hays RD, et al. Comparing the alcohol-related problems survey (ARPS) to traditional alcohol screening measures in elderly outpatients. Arch Gerontol Geriatr 2002;34:55-78.
21. National Institute on Alcohol Abuse and Alcoholism (NIAAA). Assessing alcohol problems: A guide for clinicians and researchers. 2nd ed. NIH publication No. 03-3745. Washington, DC: US Department of Health and Human Services, Public Health Service; 2003.
22. Bradley KA, Bush KR, Epler AJ, et al. Two brief alcohol-screening tests from the Alcohol Use Disorders Identification Test (AUDIT): Validation in a female Veterans Affairs patient population. Arch Intern Med 2003;163:821-829.
23. Aertgeerts B, Buntinx F, Kester A. The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: A diagnostic meta-analysis. J Clin Epidemiol 2004;57:30-39.
24. Hoeksema HL, de Bock GH. The value of laboratory tests for the screening and recognition of alcohol abuse in primary care patients. J Fam Pract 1993;37:268-276.
25. Peterson K. Biomarkers for alcohol use and abuse—A summary. Alcohol Res Health 2004;28:30-37.
26. Oslin D, Pettinati H, Volpicelli J. Alcoholism treatment adherence: Older age predicts better adherence and drinking outcomes. Am J Geriatr Psychiatry 2002;10:740-747.
27. Barry KL, Blow FC, Cullianane P, et al. The effectiveness of implementing a brief alcohol intervention with older adults in community settings. Washington, DC: National Council on Aging; 2006. Accessed 20 April 2010. www.healthyagingprograms.org/content.asp?sectionid=71&ElementID=375.
28. Offsay J. Treatment of alcohol-related problems in the elderly. Ann Longterm Care 2007;15:7450. Accessed 18 April 2010. www.annalsoflongtermcare.com/article/7450.
29. Fein G, McGillivray S. Cognitive performance in long-term abstinent elderly alcoholics. Alcohol Clin Exp Res 2007;31:1788-1799.
30. Uekermann J, Daum I. The neuropsychology of alcoholism. In: Columbus AM (ed). Advances in psychology research. Volume 49. Hauppauge, NY: Nova Science Publishers; 2007: 167-184.
Dr Rogers is a geriatric psychiatry fellow in the Department of Psychiatry at the University of British Columbia. Dr Wiese is a clinical instructor in the Department of Psychiatry at the University of British Columbia. She is also a psychiatrist with the UBC Hospital Mood Disorders Centre, and the Geriatric Psychiatry Outreach Team at Vancouver General Hospital.
Above is the information needed to cite this article in your paper or presentation. The International Committee
of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally
accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
About the ICMJE and citation styles
The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.
An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.
BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:
- Only the first three authors are listed, followed by "et al."
- There is no period after the journal name.
- Page numbers are not abbreviated.
For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org